TGA consultation: orphan drugs program

TGA

The TGA is considering whether the Orphan Drugs Program is still fulfilling its intended purpose: to provide an incentive to sponsors to bring medicines for a small population to market, and in doing so make medicines available to patients that otherwise would not be available.

The purpose of this paper is to seek your input on this issue and, in particular, on four potential options for program reform if changes are required to ensure the program objectives continue to be met.

For more details, go to: http://www.tga.gov.au/consultation/consultation-orphan-drugs-program

Michael Wonder

Posted by:

Michael Wonder

Posted in: